inTEST (INTT) Competitors $8.87 -0.11 (-1.22%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends INTT vs. ALNT, QTRX, QSI, NAUT, KEQU, FEIM, AKYA, SEER, OPTX, and MASSShould you be buying inTEST stock or one of its competitors? The main competitors of inTEST include Allient (ALNT), Quanterix (QTRX), Quantum-Si (QSI), Nautilus Biotechnology (NAUT), Kewaunee Scientific (KEQU), Frequency Electronics (FEIM), Akoya Biosciences (AKYA), Seer (SEER), Syntec Optics (OPTX), and 908 Devices (MASS). These companies are all part of the "measuring and control equipment" industry. inTEST vs. Allient Quanterix Quantum-Si Nautilus Biotechnology Kewaunee Scientific Frequency Electronics Akoya Biosciences Seer Syntec Optics 908 Devices inTEST (NYSE:INTT) and Allient (NASDAQ:ALNT) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, profitability, analyst recommendations, institutional ownership, community ranking and media sentiment. Which has stronger valuation & earnings, INTT or ALNT? Allient has higher revenue and earnings than inTEST. Allient is trading at a lower price-to-earnings ratio than inTEST, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioinTEST$123.30M0.89$9.34M$0.2338.57Allient$548.96M0.79$24.10M$0.8829.32 Do analysts rate INTT or ALNT? inTEST currently has a consensus price target of $16.00, indicating a potential upside of 80.38%. Allient has a consensus price target of $29.33, indicating a potential upside of 13.70%. Given inTEST's stronger consensus rating and higher probable upside, equities analysts plainly believe inTEST is more favorable than Allient.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score inTEST 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33Allient 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Does the media prefer INTT or ALNT? In the previous week, inTEST had 1 more articles in the media than Allient. MarketBeat recorded 5 mentions for inTEST and 4 mentions for Allient. Allient's average media sentiment score of 1.17 beat inTEST's score of 0.22 indicating that Allient is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment inTEST 0 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Allient 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community believe in INTT or ALNT? inTEST received 7 more outperform votes than Allient when rated by MarketBeat users. However, 66.67% of users gave Allient an outperform vote while only 57.89% of users gave inTEST an outperform vote. CompanyUnderperformOutperforminTESTOutperform Votes1157.89% Underperform Votes842.11% AllientOutperform Votes466.67% Underperform Votes233.33% Which has more volatility and risk, INTT or ALNT? inTEST has a beta of 1.85, meaning that its share price is 85% more volatile than the S&P 500. Comparatively, Allient has a beta of 1.61, meaning that its share price is 61% more volatile than the S&P 500. Is INTT or ALNT more profitable? Allient has a net margin of 2.64% compared to inTEST's net margin of 2.33%. Allient's return on equity of 10.80% beat inTEST's return on equity.Company Net Margins Return on Equity Return on Assets inTEST2.33% 5.31% 3.42% Allient 2.64%10.80%4.75% Do insiders & institutionals have more ownership in INTT or ALNT? 63.2% of inTEST shares are held by institutional investors. Comparatively, 61.6% of Allient shares are held by institutional investors. 5.5% of inTEST shares are held by company insiders. Comparatively, 15.6% of Allient shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. SummaryAllient beats inTEST on 10 of the 18 factors compared between the two stocks. Get inTEST News Delivered to You Automatically Sign up to receive the latest news and ratings for INTT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INTT vs. The Competition Export to ExcelMetricinTESTInstruments to measure electricity IndustryComputer SectorNYSE ExchangeMarket Cap$106.92M$4.97B$26.77B$19.47BDividend YieldN/A0.42%2.78%3.70%P/E Ratio19.6420.94200.5034.95Price / Sales0.893.033,251.2118.79Price / Cash5.8919.8434.3719.84Price / Book1.124.458.415.76Net Income$9.34M$136.22M$672.98M$993.25M7 Day Performance2.66%-0.43%2.05%3.26%1 Month Performance16.10%1.45%6.09%5.71%1 Year Performance-29.94%6.82%25.94%18.85% inTEST Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INTTinTEST2.8336 of 5 stars$8.87-1.2%$16.00+80.4%-29.5%$106.92M$123.30M19.64320Gap DownALNTAllient4.584 of 5 stars$23.46+0.6%$29.33+25.0%-7.2%$395.18M$548.96M26.661,950Short Interest ↓News CoveragePositive NewsQTRXQuanterix2.4676 of 5 stars$9.11-3.3%$23.25+155.2%-59.9%$350.95M$132.53M-8.68460News CoverageGap DownQSIQuantum-Si2.3504 of 5 stars$1.96-26.0%$3.25+65.8%+43.6%$279.72M$2.27M-3.06150Analyst ForecastOptions VolumeGap DownNAUTNautilus Biotechnology3.1137 of 5 stars$1.84+4.5%$3.58+94.7%-35.5%$231.04MN/A-3.29130Short Interest ↓News CoveragePositive NewsKEQUKewaunee Scientific1.8721 of 5 stars$57.38-0.6%N/A+114.2%$164.80M$199.64M9.091,006Short Interest ↓FEIMFrequency Electronics1.6093 of 5 stars$16.60-2.4%N/A+64.0%$159.54M$60.19M20.24200Short Interest ↑AKYAAkoya Biosciences2.0976 of 5 stars$2.96-2.3%$5.43+83.4%-42.2%$146.71M$86.82M-2.5190Gap DownSEERSeer1.914 of 5 stars$2.33-2.9%$3.00+28.8%+42.2%$137.39M$14.18M-1.79160OPTXSyntec Optics0.281 of 5 stars$2.11-20.1%N/A-48.4%$77.41M$29.39M0.003Short Interest ↑Negative NewsMASS908 Devices2.8664 of 5 stars$2.04-9.7%$8.00+292.2%-61.0%$71.04M$55.16M-1.1560Analyst ForecastAnalyst RevisionNews CoveragePositive News Related Companies and Tools Related Companies ALNT Competitors QTRX Competitors QSI Competitors NAUT Competitors KEQU Competitors FEIM Competitors AKYA Competitors SEER Competitors OPTX Competitors MASS Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:INTT) was last updated on 1/19/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding inTEST Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share inTEST With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.